Watch Ticker

Agenus Inc.

Go to Agenus Inc. Website

$5.51

0.15 (2.80%)

Live

Previous Close

$5.36

Day Range

$5.37 - $5.5896

Previous Day Range

$5.34 - $5.63

Market Cap

$147.0 million USD

Day Vol.

345488

Previous Day Vol.

269139

Currency

USD

Primary Exchange

Nasdaq

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Th...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

Several biotech companies are developing innovative cancer treatments, with promising clinical trial results in various cancer types, focusing on immunotherapy and personalized medicine approaches.

Related tickers: ONCY, CELC, LYEL, EVAX, AGEN.

Read Full Article

Researchandmarkets.Com - Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030

The global market for Neoantigen Cancer Vaccines is expected to grow significantly, driven by advancements in precision oncology, next-generation sequencing, and bioinformatics. Key players in this burgeoning market include Agenus Inc., BioNTech SE, and Candel Therapeutics.

Related tickers: AGEN.

Read Full Article

Trending Tickers

Please sign in to view